Valion Bio, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-09-30

Reported

2025-11-14

Disclosure lag

45 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Valion Bio, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001787740/2026-07-26
Event ID	#51395

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001437749-25-035216",
  "canonical_covered": 12,
  "canonical_total": 12,
  "fiscal_period": "Q3",
  "fiscal_year": 2025,
  "form": "10-Q",
  "mapped_tag_share": 0.048701298701298704,
  "metrics": {
    "cash_and_equivalents": 3450000,
    "earnings_per_share_basic": -1.97,
    "gross_profit": -145000,
    "net_income": -2596000,
    "operating_income": -2483000,
    "revenue": 146000,
    "shareholders_equity": 5591000,
    "shares_outstanding": 1662921,
    "total_assets": 6229000,
    "total_liabilities": 638000
  },
  "metrics_reported": 10,
  "period_end": "2025-09-30"
}

Source: SEC EDGAR · as of 2025-11-14T00:00:00Z